行情

GRFS

GRFS

基立福
NASDAQ

实时行情|Nasdaq Last Sale

22.21
+0.03
+0.14%
交易中 14:29 11/22 EST
开盘
22.25
昨收
22.18
最高
22.38
最低
22.16
成交量
37.11万
成交额
--
52周最高
23.03
52周最低
17.42
市值
151.95亿
市盈率(TTM)
25.41
分时
5日
1月
3月
1年
5年

分析师评级

4位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

GRFS 新闻

  • 27 Dividend Boosts Announced November 18
  • Seeking Alpha - Article.1天前
  • Is Grifols (BME:GRF) A Risky Investment?
  • Simply Wall St..3天前
  • Tracking George Soros's Portfolio - Q3 2019 Update
  • Seeking Alpha - Article.4天前
  • 上海莱士斥资132亿元并购 欲回归主营业务自救
  • 国际金融报.11/13 13:47

更多

所属板块

制药
+0.52%
制药与医学研究
+0.76%

热门股票

名称
价格
涨跌幅

GRFS 简况

Grifols SA is a Spain-based company engaged in the biopharmaceuticals manufacture. The Company’s activities are divided into four business segments: Bioscience, Hospital, Diagnostic and Raw materials. The Bioscience division focuses on the research, development, manufacturing and marketing of products derived from human plasma for therapeutic use. The Hospital division offers non-biological pharmaceutical products and medical supplies for hospital pharmacy. The Diagnostic division provides clinical analysis and laboratory testing tools to laboratories, hospitals and blood banks. The Raw materials division includes sales of intermediate biological products, as well as manufacturing services to third parties. The Company operates production facilities in Spain, the United States, Mexico and Australia, among others. It controls numerous subsidiaries, such as Kiro Grifols SL.
展开

Webull提供Grifols SA - ADR的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。